IS
INNOVATIVE SOLUTIONS & SUPPORT INC (ISSC)·Q2 2025 Earnings Summary
Executive Summary
- Q2 2025 delivered net revenue of $21.9M (+104% y/y), gross margin 51.4%, diluted EPS $0.30, and adjusted EBITDA $7.7M; driven by F-16/Honeywell product lines and air transport strength .
- The quarter beat Wall Street consensus on revenue ($15.4M*) and EPS ($0.12*) and exceeded EBITDA expectations ($4.46M*); management highlighted operating leverage from military mix and low incremental OpEx as drivers of the upside .
- Backlog remained strong at ~$79.6M with $20.8M in new orders, supporting >30% full‑year revenue and EBITDA growth guidance; facility expansion to triple capacity remains on track by mid‑year .
- Near‑term catalysts: continued Honeywell transition and potential further revenue pull‑forward into Q3, ERP integration benefits, and growing defense contribution (~≥40% of FY25 sales mix) .
Note: Values marked with * are retrieved from S&P Global.
What Went Well and What Went Wrong
What Went Well
- Strong top-line and profitability: revenue doubled to $21.9M; adjusted EBITDA rose to $7.7M (+219% y/y), with diluted EPS at $0.30; management emphasized operating leverage from incremental military revenues .
- Execution on strategic initiatives: ERP integration completed, DFARS compliance progress, and Exton facility expansion on track to increase capacity >3x by mid‑2025 .
- Defense momentum and platform integration: F‑16 product line contributions and normalized gross margins under Honeywell contracts drove sequential gross margin recovery to 51.4% (from 41.4% in Q1) .
What Went Wrong
- Gross margin volatility persists: management reiterated margins will remain “lumpy” given product mix and Honeywell transition; they encourage focusing on EBITDA/profit margins over gross margin targeting .
- Free cash flow turned negative in the quarter due to higher capex tied to facility expansion (Q2 FCF: -$0.27M) despite positive operating cash flow .
- Continued dependence on Honeywell supply chain during the transition introduces execution risk; management expects pull‑forward to continue into Q3 but cannot predict magnitude precisely .
Financial Results
Quarterly Trend (oldest → newest)
Year-over-Year Comparison (Q2 2024 → Q2 2025)
Consensus vs Actual (Q2 2025)
Note: Values marked with * are retrieved from S&P Global.
Segment Breakdown (Product vs Services)
Q2 Attribution Details
KPIs and Balance Sheet
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “Revenues more than doubling to $21.9 million and our adjusted EBITDA increasing by 219% to $7.7 million…driven by contributions from our F‑16 product line and the air transport market.” — CEO Shahram Askarpour .
- “We completed the integration of our NetSuite ERP system…we remain in a strong financial position with ample liquidity…” — CFO Jeffrey DiGiovanni .
- “Gross margins…are very volatile and kind of lumpy…we’ve been trying to steer everybody away from gross margins and put a focus on EBITDA margins and profit margins.” — CEO Askarpour .
- “We generated more normalized gross margins under our Honeywell contracts…incremental military revenues came through with little to no incremental SG&A expenses, resulting in meaningful operating leverage.” — CFO DiGiovanni .
Q&A Highlights
- Honeywell pull‑forward: Q2 benefited from pull‑forward on F‑16; similar dynamic may repeat in Q3 though magnitude uncertain; supply chain coordination with Honeywell/Lockheed continues .
- Air transport demand: Aftermarket retrofits strong amid OEM production delays; interest rates viewed as not material to demand .
- Margin outlook: Management reiterated gross margin lumpiness with mix; emphasis on EBITDA/profit margins; sequential margin improved to 51.4% .
- Mix and defense exposure: At least ~40% FY25 military revenue; ~$10.3M Q2 associated with F‑16 (product/service), and legacy revenue a bit north of $11M .
- CapEx and capacity: FY25 CapEx ~$6M; Exton facility projected eventual capability near ~$250M revenue; clean room expansion controlled and on track .
Estimates Context
- Q2 2025 vs S&P Global consensus: Revenue $21.94M vs $15.37M* (Beat); EPS $0.30 vs $0.12* (Beat); EBITDA $7.63M vs $4.46M* (Beat). Upside driven by F‑16/Honeywell contributions, product mix, and low incremental OpEx enabling operating leverage .
- Coverage depth remains thin (# of estimates: 1 for EPS and revenue in Q2 2025*), so revisions may be more volatile around each print.
Note: Values marked with * are retrieved from S&P Global.
Key Takeaways for Investors
- Q2 print was a broad-based beat with strong operating leverage from defense mix; expect continued mix-driven margin volatility but growing EBITDA/profitability as Honeywell integrates .
- Backlog ($79.6M) and new orders ($20.8M) underpin >30% FY25 revenue/EBITDA growth guidance; watch Q3 for additional revenue timing benefit from Honeywell transition .
- ERP integration and DFARS compliance are execution milestones that should improve decision velocity and support larger DoD bids; capacity expansion is an oncoming scaling catalyst .
- Near-term watch items: Honeywell/Lockheed supply chain execution risk; quarterly gross margin lumpiness tied to product mix; sustained capex for facility expansion .
- Medium-term thesis: increasing defense exposure with low incremental OpEx, vertical integration, and U.S.-based manufacturing are competitive advantages—supporting sustained EBITDA growth even with lower gross margins vs commercial .
- Potential stock catalysts: Q3 follow-through on F‑16 transition/pull-forward, UMS2 flight test progress, and visibility on additional acquisitions/product lines .
- Valuation/estimates sensitivity: With only one covering estimate*, positive/negative surprises can drive outsized reaction; focus on backlog conversion, mix, and EBITDA trajectory.
Note: Values marked with * are retrieved from S&P Global.